According to REGENXBIO's latest financial reports the company has โน23.87 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $โน22.27 B | -14.17% |
2023-12-31 | $โน25.95 B | -39.24% |
2022-12-31 | $โน42.71 B | -24.91% |
2021-12-31 | $โน56.88 B | 105.92% |
2020-12-31 | $โน27.62 B | -13.95% |
2019-12-31 | $โน32.10 B | -9.77% |
2018-12-31 | $โน35.57 B | 204.45% |
2017-12-31 | $โน11.68 B | 6.33% |
2016-12-31 | $โน10.99 B | -23.72% |
2015-12-31 | $โน14.40 B | -4089.72% |
2014-12-31 | $-โน0.37 Billion | 172.77% |
2013-12-31 | $-โน0.14 Billion |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | โน19.13 B | -19.86% | ๐บ๐ธ USA |